These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 37384792

  • 21. The influence of HIV-related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study.
    Velloza J, Khoza N, Scorgie F, Chitukuta M, Mutero P, Mutiti K, Mangxilana N, Nobula L, Bulterys MA, Atujuna M, Hosek S, Heffron R, Bekker LG, Mgodi N, Chirenje M, Celum C, Delany-Moretlwe S, HPTN 082 study group.
    J Int AIDS Soc; 2020 Mar; 23(3):e25463. PubMed ID: 32144874
    [Abstract] [Full Text] [Related]

  • 22. Acceptability, safety, and patterns of use of oral tenofovir disoproxil fumarate and emtricitabine for HIV pre-exposure prophylaxis in South African adolescents: an open-label single-arm phase 2 trial.
    Gill K, Johnson L, Dietrich J, Myer L, Marcus R, Wallace M, Pidwell T, Mendel E, Fynn L, Jones K, Wiesner L, Slack C, Strode A, Spiegel H, Hosek S, Rooney J, Gray G, Bekker LG.
    Lancet Child Adolesc Health; 2020 Dec; 4(12):875-883. PubMed ID: 33222803
    [Abstract] [Full Text] [Related]

  • 23. Psychosocial determinants of pre-exposure prophylaxis use among pregnant adolescent girls and young women in Cape Town, South Africa: A qualitative study.
    Haribhai S, Khadka N, Mvududu R, Mashele N, Bekker LG, Gorbach P, Coates TJ, Myer L, Joseph Davey DL.
    Int J STD AIDS; 2023 Jul; 34(8):548-556. PubMed ID: 36947792
    [Abstract] [Full Text] [Related]

  • 24. Assessing acceptability of pre-exposure prophylaxis (PrEP) among participants in an HIV vaccine preparedness study in southwestern Uganda.
    Nakamanya S, Kawuma R, Kibuuka D, Kusemererwa S, McCormack S, Ruzagira E, Seeley J, PrEPVacc Study Group.
    PLoS One; 2022 Jul; 17(7):e0271104. PubMed ID: 35905052
    [Abstract] [Full Text] [Related]

  • 25. Exploring adolescent girls and young women's PrEP-user profiles: qualitative insights into differentiated PrEP delivery platform selection and engagement in Cape Town, South Africa.
    Rousseau E, Sikkema KJ, Julies RF, Mazer K, O'Malley G, Heffron R, Morton JF, Johnson R, Celum C, Baeten JM, Bekker LG.
    J Int AIDS Soc; 2024 May; 27(5):e26254. PubMed ID: 38695101
    [Abstract] [Full Text] [Related]

  • 26. Stated product formulation preferences for HIV pre-exposure prophylaxis among women in the VOICE-D (MTN-003D) study.
    Luecke EH, Cheng H, Woeber K, Nakyanzi T, Mudekunye-Mahaka IC, van der Straten A, MTN-003D Study Team.
    J Int AIDS Soc; 2016 May; 19(1):20875. PubMed ID: 27247202
    [Abstract] [Full Text] [Related]

  • 27. Factors that influence adolescent girls and young women's re-initiation or complete discontinuation from daily oral PrEP use: a qualitative study from Eastern Cape Province, South Africa.
    de Vos L, Mudzingwa EK, Fynn L, Atujuna M, Mugore M, Gandhi M, Celum C, Hosek S, Bekker LG, Daniels J, Medina-Marino A.
    J Int AIDS Soc; 2023 Sep; 26(9):e26175. PubMed ID: 37758649
    [Abstract] [Full Text] [Related]

  • 28. The potential effect of pre-exposure prophylaxis (PrEP) roll-out on sexual-risk behaviour among adolescents and young people in East and southern Africa.
    Ssemata AS, Muhumuza R, Stranix-Chibanda L, Nematadzira T, Ahmed N, Hornschuh S, Dietrich JJ, Tshabalala G, Atujuna M, Ndekezi D, Nalubega P, Awino E, Weiss HA, Fox J, Seeley J.
    Afr J AIDS Res; 2022 Mar; 21(1):1-7. PubMed ID: 35361057
    [Abstract] [Full Text] [Related]

  • 29. "Killing two birds with one stone" - a qualitative study on women's perspectives on the dual prevention pill in Johannesburg, South Africa.
    Tenza S, Mampuru L, Moji M, Zulu S, Begg L, Bruce IV, Reddy K, Friedland BA, Palanee-Phillips T, Mathur S.
    BMC Womens Health; 2024 Aug 22; 24(1):462. PubMed ID: 39174929
    [Abstract] [Full Text] [Related]

  • 30. Key stakeholders' perspectives on providing oral pre-exposure prophylaxis as HIV-prevention standard of care in clinical trials in South Africa.
    Beesham I, Milford C, Joseph Davey DL, Smit J, Mansoor LE, Beksinska M.
    Afr J AIDS Res; 2023 Apr 22; 22(1):18-26. PubMed ID: 36951406
    [Abstract] [Full Text] [Related]

  • 31. Strengthening health system's capacity for pre-exposure prophylaxis for adolescent girls and young women and adolescent boys and young men in South Africa (SHeS'Cap-PrEP): Protocol for a mixed methods study in KwaZulu-Natal, South Africa.
    Nicol E, Ramraj T, Hlongwa M, Basera W, Jama N, Lombard C, McClinton-Appollis T, Govindasamy D, Pass D, Funani N, Aheron S, Paredes-Vincent A, Drummond J, Cheyip M, Dladla S, Bedford J, Mathews C.
    PLoS One; 2022 Apr 22; 17(3):e0264808. PubMed ID: 35298487
    [Abstract] [Full Text] [Related]

  • 32. Depression Among Pregnant and Breastfeeding Persons Participating in Two Randomized Trials of the Dapivirine Vaginal Ring and Oral Pre-Exposure Prophylaxis (PrEP) in Malawi, South Africa, Uganda, and Zimbabwe.
    Stoner MCD, Mathebula F, Sedze N, Seyama L, Mohuba R, Fabiano Z, Etima J, Young A, Scheckter R, van der Straten A, Piper J, Noguchi L, Montgomery ET, Balán IC.
    AIDS Behav; 2024 Jul 22; 28(7):2264-2275. PubMed ID: 38526641
    [Abstract] [Full Text] [Related]

  • 33. A community-based mobile clinic model delivering PrEP for HIV prevention to adolescent girls and young women in Cape Town, South Africa.
    Rousseau E, Bekker LG, Julies RF, Celum C, Morton J, Johnson R, Baeten JM, O'Malley G.
    BMC Health Serv Res; 2021 Aug 28; 21(1):888. PubMed ID: 34454505
    [Abstract] [Full Text] [Related]

  • 34. Preference for novel biomedical HIV pre-exposure prophylaxis methods among adolescent girls and young women in Kampala, Uganda: a mixed methods study.
    Mayanja Y, Kayesu I, Kamacooko O, Lunkuse JF, Muturi-Kioi V, Price M, Kosidou K, Ekström AM.
    Front Public Health; 2024 Aug 28; 12():1369256. PubMed ID: 38846614
    [Abstract] [Full Text] [Related]

  • 35. Determinants of heterosexual men's demand for long-acting injectable pre-exposure prophylaxis (PrEP) for HIV in urban South Africa.
    Cheng CY, Quaife M, Eakle R, Cabrera Escobar MA, Vickerman P, Terris-Prestholt F.
    BMC Public Health; 2019 Jul 24; 19(1):996. PubMed ID: 31340785
    [Abstract] [Full Text] [Related]

  • 36. Perspectives of South African youth in the development of an implant for HIV prevention.
    Krogstad EA, Atujuna M, Montgomery ET, Minnis A, Ndwayana S, Malapane T, Shapley-Quinn MK, Manenzhe K, Bekker LG, van der Straten A.
    J Int AIDS Soc; 2018 Aug 24; 21(8):e25170. PubMed ID: 30152004
    [Abstract] [Full Text] [Related]

  • 37. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P.
    Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557
    [Abstract] [Full Text] [Related]

  • 38. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
    Hugo JM, Stall RD, Rebe K, Egan JE, De Swardt G, Struthers H, McIntyre JA.
    AIDS Behav; 2016 Dec 01; 20(Suppl 3):357-364. PubMed ID: 27631366
    [Abstract] [Full Text] [Related]

  • 39. Adolescent-Centered HIV Prevention: Perspectives on Acceptability of Oral Antiretroviral Pre-exposure Prophylaxis for Adolescents in a Global Priority Setting.
    Giovenco D, Kuo C, Underhill K, Hoare J, Operario D.
    Arch Sex Behav; 2021 Oct 01; 50(7):2921-2931. PubMed ID: 34561792
    [Abstract] [Full Text] [Related]

  • 40. Preferences for long-acting Pre-Exposure Prophylaxis (PrEP) for HIV prevention among South African youth: results of a discrete choice experiment.
    Minnis AM, Atujuna M, Browne EN, Ndwayana S, Hartmann M, Sindelo S, Ngcwayi N, Boeri M, Mansfield C, Bekker LG, Montgomery ET.
    J Int AIDS Soc; 2020 Jun 01; 23(6):e25528. PubMed ID: 32544303
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.